The COCOON trial compared SOC with prophylactic management for treatment-related dermatologic events with amivantamab plus lazertinib. In this Q&A, Dr. Martin F. Dietrich explains the prophylactic regimen’s impact on effects of the skin, scalp, and nails. APP Alyson Singer offers best practices for patient education. Read more
By Anna Farago, MD, PhD Posted: June 2018 Small cell lung cancer (SCLC) accounts for approximately 15% of all new lung cancer diagnoses in the United States. Approximately 30% of […] Read more
Biosimilars have proven themselves to the U.S. FDA, but clinicians are still wary. By Leah K. Lawrence Posted: June 2018 Healthcare providers are more than familiar with the use of […] Read more
By Tiziana Vavalà, MD, andSilvia Novello, MD, PhD Posted: April 2018 Approximately 1.8 million new lung cancer cases worldwide are diagnosed annually, and 85% of these cases are NSCLC. Only […] Read more
By Annemie Snoeckx, MD, andPaul E. Van Schil, MD, PhD Posted: April 2018 No universally accepted guidelines or management protocols exist for diagnosis and treatment of screen-detected nodules. Radiologic management […] Read more
Availability of next-generation sequencing continues to improve, but current technology cannot speed turnaround time of results. Posted: February 2018 The standard of care for all patients diagnosed with advanced nonsquamous […] Read more
Posted: December 2017 Experts in molecular testing discussed various issues on this topic in October at the IASLC 18th WCLC. Neal Lindeman, MD, led off the session with an overview […] Read more
By Christian Rolfo, MD, PhD, MBAh, and Philip C. Mack, PhD Posted: December 2017 In just the past decade, tremendous advancements in the treatment of metastatic non-small cell lung cancer […] Read more
By Jason K. Molitoris, MD, PhD, Anthony D. Nehlsen, MD, and Minesh P. Mehta, MD Posted: October 2017 Up to 40% of patients with advanced non-small cell lung cancer (NSCLC) […] Read more
By Mohamed Rahouma, MD, Mohamed Kamel, MD, and Jeffrey L. Port, MD A cancer diagnosis can be overwhelming, especially if someone has limited social support. Previous international reports have indicated […] Read more
Posted: June 2017 Despite very encouraging progress in the development and use of immunotherapy for patients with non-small cell lung cancer, much confusion remains regarding patient selection for each therapy. […] Read more